title: Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone.
abstract: Methylprednisolone sodium succinate (MPSS) for treatment of acute spinal cord injury (SCI) has been associated with both benefits and adverse events. MPSS administration was the standard of care for acute SCI until recently when its use has become controversial. Patients with SCI have had little input in the debate, thus we sought to learn their opinions regarding administration of MPSS. A summary of the published literature to date on MPSS use for acute SCI was created and adjudicated by 28 SCI experts. This summary was then emailed to 384 chronic SCI patients along with a survey that interrogated the patients' neurological deficits, communication with physicians and their views on MPSS administration. 77 out of 384 patients completed the survey. 28 respondents indicated being able to speak early after injury and of these 24 reported arriving at the hospital within 8 hours of injury. One recalled a physician speaking to them about MPSS and one patient reported choosing whether or not to receive MPSS. 59.4% felt that the small neurological benefits associated with MPSS were 'very important' to them (p<0.0001). Patients had 'little concern' for potential side-effects of MPSS (p = 0.001). Only 1.4% felt that MPSS should not be given to SCI patients regardless of degree of injury (p<0.0001). This is the first study to report SCI patients' preferences regarding MPSS treatment for acute SCI. Patients favor the administration of MPSS for acute SCI, however few had input into whether or not it was administered. Conscious patients should be given greater opportunity to decide their treatment. These results also provide some guidance regarding MPSS administration in patients unable to communicate.
authors.affiliation: Department of Neurosurgery, University of Utah, Salt Lake City, Utah, United States of America.
authors.forename: Christian A
authors.initials: CA
authors.lastname: Bowers
authors.affiliation: Department of Neurosurgery, University of Utah, Salt Lake City, Utah, United States of America.
authors.forename: Bornali
authors.initials: B
authors.lastname: Kundu
authors.affiliation: Department of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, Utah, United States of America.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Rosenbluth
authors.affiliation: Department of Neurosurgery, University of Utah, Salt Lake City, Utah, United States of America.
authors.forename: Gregory W J
authors.initials: GW
authors.lastname: Hawryluk
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D057240:Patient Preference; D013119:Spinal Cord Injuries / Q000188:drug therapy*
chemical_list: D008775:Methylprednisolone